SMMT
Summit Therapeutics Inc.
There isn't enough reported data to score SMMT yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
SMMT Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
SMMT's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
SMMT PE Valuation
SMMT has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
SMMT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Stable | |
| -- | |
| Limited | |
| Low |
Analysts expect SMMT's losses to grow, with revenue holding steady. However, they disagree widely on these estimates.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
SMMT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.06 | +$0.18 |
| Q2 2026 | -$1.11 | -$0.10 |
| Q1 2026 | -$1.59 | -$1.25 |
| Q4 2025 | -$1.44 | -$1.13 |
| Q3 2025 | -$1.24 | -$0.96 |
| Q2 2025 | -$1.01 | -$0.78 |
| Q1 2025 | -$0.34 | -$0.18 |
| Q4 2024 | -$0.31 | +$1.22 |
SMMT lost $1.06 per share over the past year, a smaller loss than the year before.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over SMMT on earnings quality, reporting a profit while its opponent remains loss making.
SMMT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2022 | $220K | -83% |
| Q2 2022 | $235K | +312% |
| Q1 2022 | $250K | +30% |
| Q4 2021 | $251K | +36% |
| Q3 2021 | $1.3M | +623% |
SMMT's revenue has slid since its 2021 peak: $0 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2022 | -7700% | -6211 points |
| Q2 2022 | -5401% | +36231 points |
| Q1 2022 | -8863% | -49 points |
| Q4 2021 | -10377% | -3054 points |
| Q3 2021 | -1489% | +8576 points |
| Q2 2021 | -41632% | N/A |
| Q1 2021 | -8814% | N/A |
| Q4 2020 | -7324% | N/A |
SMMT's operating margin was −7700% last quarter, down 6211 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
SMMT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$160.2M | -$67.1M |
| Q2 2026 | -$142M | -$75.3M |
| Q1 2026 | -$122.5M | -$60.9M |
| Q4 2025 | -$102.1M | -$53.4M |
| Q3 2025 | -$93.2M | -$62.8M |
| Q2 2025 | -$66.7M | -$33.7M |
| Q1 2025 | -$61.6M | -$31.5M |
| Q4 2024 | -$48.7M | -$29.2M |
SMMT has burned cash in almost every quarter: −$527M over the past year, against −$270M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over SMMT on cash generation, producing positive trailing cash flow while its opponent burns cash.
SMMT Net Leverage
SMMT's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
SMMT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.2 | Neutral |
| Stochastic | 53.3 | Neutral |
SMMT's weekly RSI is 47 (neutral) and its Stochastic is 53 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
SMMT PE vs Healthcare Sector
SMMT has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
SMMT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $15.9 | 5.5% below |
| 20 week MA | $15.3 | 1.4% below |
| 50 week MA | $16.3 | 7.8% below |
| 100 week MA | $19.0 | 21% below |
| 200 week MA | $12.6 | 19% above |
SMMT has fallen below most of its moving averages, though it's still 19% above its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over SMMT on trend strength, trading above more of its moving averages.
SMMT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.55 | $5.70 | +268% |
| 2021 | $5.70 | $3.03 | -47% |
| 2022 | $3.03 | $3.67 | +21% |
| 2023 | $3.67 | $2.61 | -29% |
| 2024 | $2.61 | $18.2 | +598% |
| 2025 | $18.2 | $18.1 | -0.4% |
| 2026 YTD | $18.1 | $15.1 | -17% |
SMMT's yearly returns have swung widely, from +598% in 2024 to −47% in 2021. It's down 17% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over SMMT on returns for 2026, with the stronger performance.